Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes

From MaRDI portal
Revision as of 15:42, 25 April 2024 by Import240425040427 (talk | contribs) (Created automatically from import240425040427)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:67231

DOI10.1371/journal.pgen.1009557WikidataQ112722487 ScholiaQ112722487MaRDI QIDQ67231

Zaoke He, Xiangyu Zhao, Shixiang Wang, Minfang Song, Kai Wu, Ziyu Tao, Tao Wu, Xue-Song Liu, Huimin Li

Publication date: 4 May 2021

Published in: PLOS Genetics (Search for Journal in Brave)




Related Items (2)




This page was built for publication: Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes